Imunexus - IPO for innovative biotechnology company

Want to win a job like this?
This customer received 240 logo designs from 47 designers. They chose this logo design from logo_s as the winning design.
Join for free Find Design Jobs- Guaranteed
Logo Design Brief
We need a logo design for a new biotechnology company based in Melbourne, Australia. The company is called Imunexus, and is preparing for an initial public offering (IPO) on the Australian Stock Exchange (ASX). Imunexus offers a 'plug-and-play' technology platform for rapid development of 'biobetters', the rough equivalent of 'super-generic' drugs. Biobetters are improved biological drugs (e.g. antibodies) that are similar to the original antibody, but have substantive structural modifications that enhance the efficacy of the drug. Biobetters work much better than simple 'biosimilars' which are closer copies of the original drug, and do not work any better than the original drug. Please refer to the attached brief summary, in particular logo design concepts on page 3.
Updates
Project Deadline Extended
Reason: Need to get consensus amongst Board.
Added Tuesday, June 2, 2015
Target Market(s)
Biotechnology investors - high net worths, sophisticated, and retail
Industry/Entity Type
Biotechnology
Logo Text
Imunexus
Logo styles of interest
Pictorial/Combination Logo
A real-world object (optional text)



Character Logo
Logo with illustration or character


Look and feel
Each slider illustrates characteristics of the customer's brand and the style your logo design should communicate.
Elegant
Bold
Playful
Serious
Traditional
Modern
Personable
Professional
Feminine
Masculine
Colorful
Conservative
Economical
Upmarket
Requirements
Must have
- Please see page 3 of the attached brief. NOTE: We are not committed to the boomerang concept; it is one suggestion. Other concepts are welcome.
Nice to have
- Please see page 3 of the attached brief. Innovation, next-generation, breakthrough, combination, nexus.
Should not have
- Please see page 3 of the attached brief